Jack A. Khattar - 22 Feb 2022 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
President, CEO, Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
22 Feb 2022
Transactions value $
$0
Form type
4
Filing time
24 Feb 2022, 20:29:08 UTC
Previous filing
06 Dec 2021
Next filing
13 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 556,466 22 Feb 2022 Direct
holding SUPN Common Stock 1,058,450 22 Feb 2022 By the KBT Trust
holding SUPN Common Stock 4,000 22 Feb 2022 By son F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Employee Stock Option (Right to Buy) Award $0 +250,000 $0 250,000 22 Feb 2022 Common Stock 250,000 $32.2 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
F2 The option vests in four equal annual installments beginning on February 22, 2023.

Remarks:

Exhibit 24 - Power of Attorney